Kay Maltby

Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects

Ruth Dixon, Sarah A. Job, Ruth Oliver et al. · British Journal of Clinical Pharmacology · 2008 · 112 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Neural and Behavioral Effects of a Novel Mu Opioid Receptor Antagonist in Binge-Eating Obese People

Victoria C. Cambridge, Hisham Ziauddeen, Pradeep J. Nathan et al. · Biological Psychiatry · 2012 · 93 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist

Pradeep J. Nathan, Barry V. O’Neill, Mark Bush et al. · The Journal of Clinical Pharmacology · 2011 · 49 citations

Medicine, Pharmacokinetics, Pharmacology +17

Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals

Samuel R. Chamberlain, Karin Mogg, Brendan P. Bradley et al. · Psychopharmacology · 2012 · 28 citations

Medicine, Pharmacology, Psychology +14

The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours

Eamonn Kelly, Stuart J. Mundell, Anna Sava et al. · Psychopharmacology · 2014 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17